Wealthgate Family Office’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-7,267
Closed -$535K 29
2021
Q1
$535K Hold
7,267
0.73% 22
2020
Q4
$567K Buy
+7,267
New +$556K 0.85% 20

Other funds holding MRK

Wealthgate Family Office's MRK Position: Q2 2021 in Review

Wealthgate Family Office sold out of Merck (MRK) in Q2 2021, closing a stake of 7,267 shares — an estimated $535K sold.

Wealthgate Family Office first reported a position in MRK in Q4 2020 and held it in 2 quarters. The position peaked at $567K in Q4 2020. 2,674 funds tracked by Wall St. Rank hold MRK as of Q2 2021.

  • Wealthgate Family Office reported no remaining Merck position as of Q2 2021 after selling out during the quarter.
  • Wealthgate Family Office sold 7,267 Merck shares in Q2 2021, an estimated $535K.
  • Wealthgate Family Office first reported a position in Merck in Q4 2020 and held it in 2 quarters.
  • Wealthgate Family Office's Merck position peaked at $567K in Q4 2020.
  • 2,674 funds tracked by Wall St. Rank held Merck as of Q2 2021.

Based on Wealthgate Family Office's 13F filing for Q2 2021, filed 11 Aug 2021.